药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Brinzolamide
Niguldipine
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Niguldipine.
Brinzolamide
Lacidipine
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Lacidipine.
Brinzolamide
Efonidipine
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Efonidipine.
Brinzolamide
Aranidipine
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Aranidipine.
Brinzolamide
Pinaverium
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Pinaverium.
Brinzolamide
Vilanterol
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Vilanterol.
Brinzolamide
Olodaterol
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Olodaterol.
Brinzolamide
Flumequine
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Flumequine.
Brinzolamide
Chlorcyclizine
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Chlorcyclizine.
Brinzolamide
Dabrafenib
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Dabrafenib.
Brinzolamide
Eribulin
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Eribulin.
Brinzolamide
Rilpivirine
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Rilpivirine.
Brinzolamide
Geranylgeranyl diphosphate
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Geranylgeranyl diphosphate.
Brinzolamide
Farnesyl diphosphate
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Farnesyl diphosphate.
Brinzolamide
Triptorelin
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Triptorelin.
Brinzolamide
Histrelin
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Histrelin.
Brinzolamide
Buserelin
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Buserelin.
Brinzolamide
Degarelix
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Degarelix.
Brinzolamide
Pasireotide
The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Mepyramine.
Brinzolamide
Cariporide
The risk or severity of QTc prolongation can be increased when Cariporide is combined with Mepyramine.